Lesaffre completed an investment in CanBiocin.

Lesaffre, a yeast manufacturer, completed an investment in CanBiocin, a biotechnology company. Financial terms were not disclosed. “This strategic move perfectly aligns with Lesaffre’s unwavering commitment to customer proximity. Together with CanBiocin with whom we share common values, we will expand our ability to provide comprehensive offerings and extensive portfolios that address our clients’ complete needs with end-to-end solutions. We are confident that the combination of Phileo’s and CanBiocin’s expertise will allow us to better serve the evolving needs of pet owners and animal feed producers worldwide,” Brice-Audren Riché, Lesaffre CEO.